Coegin Pharma
3.43 SEK
-6.03 %
Less than 1K followers
COEGIN
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Coegin Pharma
EV/EBIT
Median 2019-2022
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 0.98 | 16.80 | 32.07 | 11.98 | 4.79 | 3.85 | 4.44 |
| Shares | 0.0 | 6.0 | 6.9 | 8.1 | 10.5 | 24.9 | 24.9 |
| Market cap | 0.0 | 100.6 | 221.0 | 96.5 | 50.6 | 95.8 | 110.5 |
| Enterprise value | -1.7 | 84.0 | 195.4 | 92.7 | - | - | - |
| EV/S | - | - | - | - | - | - | - |
| EV/EBITDA | 0.1 | neg. | neg. | neg. | - | - | - |
| EV/EBIT | 0.1 | neg. | neg. | neg. | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 0.02 | 6.02 | 10.34 | 4.59 | 7.49 | 3.79 | 23.29 |
| P/S | - | - | - | - | - | - | 1,398.2 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 35.2 % | 87.3 % | 67.6 % | 71.8 % | 43.7 % | 93.4 % | 35.5 % |
| Gearing ratio | - | - | - | - | - | - | - |